Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Cell

• Publication date

  1988-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0092-8674(88)90184-5PMID 2898299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted c‐myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription.

  1988cited by this paper
• Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene.

  1988cited by this paper
• Multiple regulatory domains in the mouse mammary tumor virus long terminal repeat revealed by analysis of fusion genes in transgenic mice

  1988cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.

  1987cited by this paper
• Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene.

  1987cited by this paper
• Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

  1987cited by this paper
• Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms.

  1987cited by this paper
• Stage- and tissue-specific expression of the neu oncogene in rat development.

  1987cited by this paper
• Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis.

  1987cited by this paper
• Deregulated c-fos expression interferes with normal bone development in transgenic mice

  1987cited by this paper
• Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

  1987cited by this paper
• Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene

  1987cited by this paper
• Prolactin and breast cancer.

  1987cited by this paper
• The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region.

  1987cited by this paper
• erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

  1987cited by this paper
• Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

  1986cited by this paper
• The neu oncogene encodes an epidermal growth factor receptor-related protein

  1986cited by this paper
• Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

  1986cited by this paper
• p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity

  1986cited by this paper
• Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development.

  1986cited by this paper
• Germ-line transformation of mice.

  1986cited by this paper
• Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats

  1985cited by this paper
• Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

  1985cited by this paper
• Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.

  1985cited by this paper
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

  1985cited by this paper
• A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.

  1985cited by this paper
• Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

  1985cited by this paper
• The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.

  1985cited by this paper
• The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

  1984cited by this paper
• Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.

  1984cited by this paper
• Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

  1984cited by this paper
• Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

  1984cited by this paper
• Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

  1984cited by this paper
• An improved in situ hybridization method for the detection of cellular RNAs in Drosophila tissue sections and its application for localizing transcripts of the homeotic Antennapedia gene complex

  1983cited by this paper
• Nucleocytoplasmic distribution of snRNPs and stockpiled snRNA-binding proteins during oogenesis and early development in Xenopus laevis.

  1983cited by this paper
• Polyoma virus transforming protein associates with the product of the c-src cellular gene

  1983cited by this paper
• Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.

  1983cited by this paper
• Preservation of hamster oocytes to assay the fertilizing capacity of human spermatozoa.

  1982cited by this paper
• Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas.

  1982cited by this paper
• Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus.

  1981cited by this paper
• Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

  1981cited by this paper
• Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

  1981cited by this paper
• Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

  1980cited by this paper
• Rapid DNA isolations for enzymatic and hybridization analysis.

  1980cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

  1977cited by this paper
• Detection of specific sequences among DNA fragments separated by gel electrophoresis.

  1975cited by this paper

• Induction of senescence during postpartum mammary gland involution supports tissue remodeling and promotes postpartum tumorigenesis.

  2026cites this paper
• Insights from Genomic Sequencing of Preclinical Breast Cancer Models Establish Human Parallels to Increase Therapeutic Applicability.

  2026cites this paper
• Lifelong n-3 PUFA Consumption Reduces HER2+ Mammary Tumour Growth and Alters Immune Markers Compared to Safflower- or Corn Oil-Based Sources of n-6 PUFA.

  2026cites this paper
• HER2-driven mammary tumorigenesis enhances bioenergetics despite reductions in mitochondrial content

  2026cites this paper
• Modeling tumor relapse using proliferation tracing and ablation transgenic mouse

  2025cites this paper
• HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma

  2025cites this paper
• Cerebellum metastasis model of HER2-positive breast cancer unveils key role of IL34-induced Arg1+ macrophages

  2025cites this paper
• Investigating the genomic landscape of mouse models of breast cancer metastasis

  2025cites this paper
• Genetic background and oncogenic driver determines the genomic evolution and transcriptomics of mammary tumor metastasis

  2025cites this paper
• A new, immunocompetent brain-metastatic mouse model of HER2-positive breast cancer

  2025cites this paper
• RANK/RANKL Signaling Pathway in Breast Development and Cancer.

  2025cites this paper
• Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Anti-tumor Immunity and Improve Immunotherapy Efficacy.

  2025cites this paper
• The impact of low-dose gamma radiation on immune modulation in a mouse model of spontaneous mammary gland tumorigenesis

  2025cites this paper
• Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer.

  2025cites this paper
• Journey of Breast Cancer from Pyramid Age to Molecular Era

  2025cites this paper
• SRSF3 is oncogenic in breast but tumor-suppressive in liver by differential regulation of gene expression

  2025cites this paper
• Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies

  2025cites this paper
• Facing the Challenge to Mimic Breast Cancer Heterogeneity: Established and Emerging Experimental Preclinical Models Integrated with Omics Technologies

  2025cites this paper
• Mouse models for cancer research - current state and the perspective.

  2024cites this paper
• ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis

  2024cites this paper
• Unlocking the epigenetic code: new insights into triple-negative breast cancer

  2024cites this paper
• Fes-deficient macrophages enhance CD8+ T cell priming and tumour control through increased pro-inflammatory cytokine production and localization

  2024cites this paper
• Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in Breast Cancer

  2024cites this paper
• Genomic Deletion of PFKFB3 Decreases In Vivo Tumorigenesis

  2024cites this paper
• Transgenic overexpression of the miR‐200b/200a/429 cluster prevents mammary tumor initiation in Neu/Erbb2 transgenic mice

  2024cites this paper
• A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice

  2024cites this paper
• Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation

  2024cites this paper
• Male reproductive phenotypes of genetically altered laboratory mice (Mus musculus): a review based on pertinent literature from the last three decades

  2024cites this paper
• Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk.

  2024cites this paper
• HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth

  2024cites this paper
• How much do we know about the metastatic process?

  2024cites this paper
• Mouse Models of HER2+ Human Breast Cancer: A Literature Review

  2024influential citation
• Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures

  2024cites this paper
• Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of 4‐Nitrobenzohydrazide Derivatives as Potential Anticancer Agents

  2023cites this paper
• Busting the Breast Cancer with AstraZeneca's Gefitinib

  2023cites this paper
• Core binding factor subunit β plays diverse and essential roles in the male germline

  2023cites this paper
• LncRNA LINK‐A Remodels Tissue Inflammatory Microenvironments to Promote Obesity

  2023cites this paper
• Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics

  2023cites this paper
• Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective

  2023cites this paper
• A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.

  2023cites this paper
• Clinical management of drug-induced cardiotoxicity in patients with HER-2+ breast cancer: current recommendations and future outlook

  2023cites this paper
• Rank ectopic expression in the presence of Neu and PyMT oncogenes alters mammary epithelial cell populations and their tumorigenic potential

  2023cites this paper
• Anticancer, Antioxidant Activity and Molecular Docking Studies of Saccharumoside-B

  2023cites this paper
• Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche

  2023cites this paper
• Lessons from other fields of medicine, Part 1: Breast cancer.

  2023cites this paper
• USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity

  2023cites this paper
• Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model

  2023cites this paper
• Mammary-specific ectopic expression of mutant human GATA3 did not potentiate medroxyprogesterone acetate-driven mouse mammary tumorigenesis

  2023cites this paper
• Dissecting metastasis using preclinical models and methods

  2023cites this paper
• Expression of Her-2/NEU in Patients With Primary Non-small Cell Lung Cancer (Nsclc)

  2023cites this paper
• Infiltrating CD8+ T cells and M2 macrophages are retained in tumor matrix tracks enriched in low tension fibronectin fibers.

  2023cites this paper
• Development of an in vivo system to model breast cancer metastatic organotropism and evaluate treatment response using the chick embryo

  2023cites this paper
• In Vivo Modeling of Tumor Heterogeneity for Immuno‐Oncology Studies: Failures, Improvements, and Hopes

  2022cites this paper
• Spatial collagen stiffening promotes collective breast cancer cell invasion by reinforcing extracellular matrix alignment

  2022cites this paper
• The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer

  2022cites this paper
• Large Animal Models of Breast Cancer

  2022cites this paper
• Blocking Gi/o-Coupled Signaling Eradicates Cancer Stem Cells and Sensitizes Breast Tumors to HER2-Targeted Therapies to Inhibit Tumor Relapse

  2022cites this paper
• ABL kinases regulate translation in HER2+ cells through Y-box-binding protein 1 to facilitate colonization of the brain

  2022cites this paper
• Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint therapy is associated with macrophage infiltration and Wnt pathway expression

  2022cites this paper
• Veterinary Management of Harderian Gland Tumors in Cancer Rainbow (crainbow) HER2-Positive Mice.

  2022cites this paper
• Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s)

  2022cites this paper
• Assessment of the Immune Response to Tumor Cell Apoptosis and Efferocytosis.

  2022cites this paper
• USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of 1 function impacts MMTV promoter activity 2

  2022cites this paper
• The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer

  2021cites this paper
• Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis

  2021cites this paper
• Advances in Rodent Models for Breast Cancer Formation, Progression, and Therapeutic Testing

  2021cites this paper
• Systemic Influences of Mammary Cancer on Monocytes in Mice

  2021cites this paper
• An Optical Tweezers-Based Single-Cell Manipulation and Detection Platform for Probing Real-Time Cancer Cell Chemotaxis and Response to Tyrosine Kinase Inhibitor PD153035

  2021cites this paper
• HER-2 as a Prognostic and Predictive Biomarker in Cancer

  2021cites this paper
• Reduction of fibrosis and immune suppressive cells in ErbB2-dependent tumorigenesis by an LXR agonist

  2021cites this paper
• Olfactory receptor 5B21 drives breast cancer metastasis

  2021influential citation
• Dual recombinase action in the normal and neoplastic mammary gland epithelium

  2021cites this paper
• Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer

  2021cites this paper
• Effects of Chronic Low-Dose Internal Radiation on Immune-Stimulatory Responses in Mice

  2021cites this paper
• Aging‐associated skeletal muscle defects in HER2/Neu transgenic mammary tumour model

  2021cites this paper
• TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis

  2021cites this paper
• Simulation and machine learning modelling based comparative study of InAlGaN and AlGaN high electron mobility transistors for the detection of HER-2.

  2021cites this paper
• Transgenic mouse models of breast cancer.

  2021cites this paper
• RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness

  2021cites this paper
• p63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer

  2021cites this paper
• Fish oil supplementation increases expression of mammary tumor apoptosis mediators and reduces inflammation in an obesity-associated HER-2 breast cancer model.

  2021cites this paper
• Use of constitutive and inducible oncogene-containing iPSCs as surrogates for transgenic mice to study breast oncogenesis

  2021cites this paper
• HER2-Positive (HER2 +) Breast Cancer

  2021cites this paper
• Applications of mass spectrometry imaging in virus research.

  2021cites this paper
• Targeting Gi/o protein–coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy

  2021cites this paper
• The microRNA analysis portal is a next-generation tool for exploring and analyzing miRNA-focused data in the literature

  2021cites this paper
• Long noncoding RNAs in cancer metastasis

  2021cites this paper
• The PTEN and ATM axis controls the G1/S cell cycle checkpoint and tumorigenesis in HER2-positive breast cancer

  2021cites this paper
• Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity

  2020cites this paper
• Keeping abreast about Ashwagandha in breast cancer.

  2020cites this paper
• Combined Broccoli Sprouts and Green Tea Polyphenols Contribute to the Prevention of Estrogen Receptor-Negative Mammary Cancer via Cell Cycle Arrest and Inducing Apoptosis in HER2/neu Mice.

  2020cites this paper
• Regulation of breast cancer oncogenesis by the cell of origin’s differentiation state

  2020cites this paper
• Her-2 Breast Cancer Outcomes Are Mitigated by Consuming n-3 Polyunsaturated, Saturated, and Monounsaturated Fatty Acids Compared to n-6 Polyunsaturated Fatty Acids

  2020cites this paper
• Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases

  2020cites this paper
• Treatment of ErbB2 breast cancer by mitochondrial targeting

  2020cites this paper
• Studying Lymphatic Metastasis in Breast Cancer: Current Models, Strategies, and Clinical Perspectives

  2020cites this paper
• In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches.

  2020cites this paper
• Antiproliferative activity of new pentacyclic triterpene and a saponin from Gladiolus segetum Ker-Gawl corms supported by molecular docking study

  2020cites this paper
• Hyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer

  2020cites this paper
• Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment

  2020cites this paper